These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 5366981

  • 21. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST.
    J Infect Dis; 2004 Jul 01; 190(1):115-22. PubMed ID: 15195250
    [Abstract] [Full Text] [Related]

  • 22. Bacille Calmette-Guérin vaccine.
    Wittes RC.
    Clin Infect Dis; 2000 Sep 01; 31 Suppl 3():S115-21. PubMed ID: 11010836
    [No Abstract] [Full Text] [Related]

  • 23. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
    Griffin JF, Chinn DN, Rodgers CR, Mackintosh CG.
    Tuberculosis (Edinb); 2001 Sep 01; 81(1-2):133-9. PubMed ID: 11463234
    [Abstract] [Full Text] [Related]

  • 24. [Comparative study of Soviet and Bulgarian BCG vaccines].
    Iablokova TB, Rozenberg AM, Pisarenko NN, Nesterenko LA, Engibarov A.
    Probl Tuberk; 1980 Jun 01; (6):60-4. PubMed ID: 7393916
    [No Abstract] [Full Text] [Related]

  • 25. [Laboratory characteristics of BCG vaccine (from Brasilian and French substrains) produced in Poland and of the original Soviet vaccine].
    Buraczewska M, Paklerska-Pobratyn H, Pichula K.
    Pediatr Pol; 1969 Dec 01; 44(12):1469-76. PubMed ID: 5371124
    [No Abstract] [Full Text] [Related]

  • 26. [On some experimental aspects of antituberculosis vaccination with BCG].
    Di Perna A, Ciaccia A, Rabinovici A.
    Lotta Tuberc; 1967 Dec 01; 37(3):Suppl:187-203. PubMed ID: 5252289
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Tuberculosis prevention by BCG vaccine].
    Hashimoto T.
    Kekkaku; 1982 Jun 01; 57(6):329-34. PubMed ID: 6757514
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J, Vipond R, Allen-Vercoe E, Clark SO, Hatch GJ, Gooch KE, Bacon J, Hampshire T, Shuttleworth H, Minton NP, Blake K, Williams A, Marsh PD.
    Vaccine; 2006 Sep 11; 24(37-39):6340-50. PubMed ID: 16781800
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The type of vaccine].
    Blasi A.
    Lotta Tuberc; 1968 Sep 11; 38(1):84-90. PubMed ID: 5252512
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [The problem of specific prevention of modern tuberculosis].
    Dikiĭ IL, Cherkas GP, Dikaia EM, Derkach SA, Bazavluk AD.
    Mikrobiol Zh (1978); 1984 Sep 11; 46(5):59-62. PubMed ID: 6443872
    [No Abstract] [Full Text] [Related]

  • 39. [Antitubercular antibodies in guinea pig blood serum].
    Oprysko OV.
    Probl Tuberk; 1971 Sep 11; 49(4):58-60. PubMed ID: 5138427
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.